<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04287127</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL20_0037</org_study_id>
    <nct_id>NCT04287127</nct_id>
  </id_info>
  <brief_title>One-stage Bone Lengthening in the Management of Brachymetatarsia</brief_title>
  <acronym>BRACHYONESTAGE</acronym>
  <official_title>Cosmetic Satisfaction and Undercorrection After One-stage Bone Lengthening in the Management of Brachymetatarsia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Brachymetatarsia is a shortening in length of a metatarsal exceeding 5mm. This congenital
      anomaly most often affecting women and the second metatarsal is associated with frequent
      aesthetic disorders leading patients to consult. The one-time lengthening technique is
      described for the management of brachymetatarsia with good functional results. However, the
      metatarsal elongation in one time is limited to 15 millimeters, to avoid complications.

      No study has presented the consequences of hypocorrection, especially cosmetic. Our
      hypothesis is that undercorrection (Hypocorrection) is associated with a higher rate of
      cosmetic dissatisfaction.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Actual">January 1, 2020</completion_date>
  <primary_completion_date type="Actual">December 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>satisfaction using a visual analog scale (from 0/10 to 10/10)</measure>
    <time_frame>1 day</time_frame>
    <description>Cosmetic evaluation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>radiological evaluation of surgical correction</measure>
    <time_frame>1 day</time_frame>
    <description>metatarsal lengtening : mesured on a dorsoplantar radiograph</description>
  </secondary_outcome>
  <enrollment type="Actual">25</enrollment>
  <condition>Brachymetatarsia</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who presented brachymetatarsia and who underwent one stage lengthening in our
        department
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients operated on for a one-time lengthening for isolated brachymetatarsia

          -  Major patients

        Exclusion Criteria:

          -  Patient refusing to participate in research
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Louis Dagneaux, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Montpellier</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Uhmontpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 5, 2020</study_first_submitted>
  <study_first_submitted_qc>February 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 27, 2020</study_first_posted>
  <last_update_submitted>February 27, 2020</last_update_submitted>
  <last_update_submitted_qc>February 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>NC</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

